About
FAQ
Reports
Contact Us
Works
Groups
People
Publications
Publishers
In Press
Advanced
Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC)
Published by:
American Society of Clinical Oncology
Authorized Title
Journal of Clinical Oncology